CLARA HUBBS: Open Payments
NPI 1609240050 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,060 in 125 payments from 14 companies in 2025. Trend: 2023 $1,629 · 2024 $1,589 · 2025 $2,060
Food & beverage: $2,060
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 25 | $426 |
| ABBVIE INC. | 25 | $406 |
| PFIZER INC. | 14 | $236 |
| AstraZeneca Pharmaceuticals LP | 10 | $199 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $196 |
| GlaxoSmithKline, LLC. | 13 | $172 |
| Lilly USA, LLC | 13 | $152 |
| Exact Sciences Corporation | 4 | $66 |
| Abbott Laboratories | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
Products named: Ozempic, ELIQUIS, XIFAXAN, VRAYLAR, UBRELVY, TRELEGY ELLIPTA, AIRSUPRA, JARDIANCE.
Industry payments across TN — which companies pay providers there.
